Dolor Technologies, LLC Information

The SphenoCath® is a patented, single-use, disposable catheter from Dolor Technologies, LLC through which a medical professional can deliver medication through the nasal passages to several difficult-to-reach ganglia (a group of nerve cells) in the face and head without needles, sprays, swabs, or sedation. Sphenopalatine Ganglion Blocks (SPG) have been performed for many years, but this new technology allows them to be performed quickly with comfort and ease. When used as indicated, the SphenoCath® delivers medication immediately proximate to the ganglia to achieve a Sphenoplatine Ganglion or SPG block and further egress of the medication into other ganglia as well. Interventional radiologists, neurologists, internists, emergency departments, pain specialists, and general practitioners are interested in utilizing the SphenoCath® for a safe, comfortable, and quick delivery of the medication required for the SPG block procedure. This drug delivery innovation, the SphenoCath®, is drawing the attention of physicians who treat patients with chronic and episodic migraine, cluster headache, and chronic daily headache and for other facial pain and headache syndromes. The patented SphenoCath® offers the practitioner the ability to offer a first-line treatment to the chronic headache patient. The SphenoCath® delivers medication that can sustain pain relief in a 15 minute procedure that is comfortable and quick. With the SphenoCath® an SPG block may be achieved without needles, cotton swabs, atomizer sprays, or systemic narcotics. SphenoCath® is a registered trademark of Dolor Technologies, LLC. Dolor Technologies holds a patent on the SphenoCath® device and the method of achieving an SPG Block via the nasal cavity. For more information or to find a SphenoCath® trained physician in your area, email: info@sphenocath.com or call (801) 386-9400 Interested in becoming a SphenoCath® Practice? Call (801) 386-9400 or email for a distributor near you.